Capital International Sarl Teva Pharmaceutical Industries LTD Transaction History

Capital International Sarl

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$8.36 - $11.37 $368,391 - $501,030	44,066 Added 16.23%	315,588 $2.79 Million
Q4 2022 Feb 14, 2023	BUY	$7.95 - $9.48 $695,680 - $829,566	87,507 Added 47.55%	271,522 $2.48 Million
Q3 2022 Nov 14, 2022	BUY	$6.86 - $11.95 $1.26 Million - $2.2 Million	184,015 New	184,015 $1.49 Million
Q1 2022 May 16, 2022	SELL	$7.33 - $9.39 $170,686 - $218,655	-23,286 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$8.38 - $10.18 $244,930 - $297,541	-29,228 Reduced 55.66%	23,286 $227,000
Q2 2021 Aug 16, 2021	SELL	$9.9 - $11.56 $134,283 - $156,799	-13,564 Reduced 20.53%	52,514 $520,000
Q1 2021 May 14, 2021	SELL	$10.34 - $12.81 $183,524 - $227,364	-17,749 Reduced 21.17%	66,078 $763,000
Q4 2020 Feb 16, 2021	BUY	$8.61 - $11.04 $195,937 - $251,237	22,757 Added 37.26%	83,827 $809,000
Q3 2020 Nov 16, 2020	BUY	$8.57 - $12.69 $86,736 - $128,435	10,121 Added 19.86%	61,070 $550,000
Q2 2020 Aug 14, 2020	BUY	$8.12 - $13.12 $314,641 - $508,386	38,749 Added 317.61%	50,949 $628,000
Q1 2020 May 15, 2020	BUY	$6.69 - $13.45 $81,618 - $164,090	12,200 New	12,200 $110,000

624

565M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Capital International Sarl, based on Form 13F filings with the SEC.

Stay updated on Capital International Sarl with notifications on news.